Karin Jooss
Fortune : 27 968 $ au 31/05/2026
Fortune : 27 968 $ au 31/05/2026
Karin Jooss is currently an Independent Director at Fate Therapeutics, Inc. since 2019.
Former positions include Executive VP & Head-Research & Development at Nexoplex Bio, Inc. from 2021 to 2024, Head-Cancer Immunotherapeutics at Pfizer Inc. from 2009 to 2016, and Vice President-Research at Cell Genesys, Inc. from 2005 to 2009.
Education includes a doctorate from Philipps University of Marburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FATE THERAPEUTICS, INC. 0,01 % | 12/06/2026 | 9 848 ( 0,01 % ) | 27 968 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 14/03/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Directeur Technique/Scientifique/R&D | 31/12/2024 |
| PFIZER INC. | Corporate Officer/Principal | 01/04/2016 |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Directeur Technique/Scientifique/R&D | 01/04/2009 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Gritstone bio, Inc.
Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national